Document is current
Any future updates will be listed below
-
Authors
Wenande, Emily https://orcid.org/0000-0002-5928-5042
Wanner, Molly
Sakamoto, Fernanda H. https://orcid.org/0000-0003-2497-4646
Paasch, Uwe https://orcid.org/0000-0003-3725-0284
Haedersdal, Merete https://orcid.org/0000-0003-1250-2035
- License Information
-
More Information
Article History
Received: 7 August 2024
Accepted: 23 January 2025
First Online: 6 February 2025
Declarations
:
: Verbal and written consent to publish anonymized patient photographs (Figure ) in this review article has been obtained.
: With no relation to the work, Emily Wenande has received a speaker honorarium from Sanofi. With no relation to the work, EW has been employed in the pharmaceutical medicine physician (PMP) programme at Novo Nordisk A/S since September 2024. Molly Wanner: grant funding and equipment from Bausch Health/Solta; equity and consulting for Ella Ola, Sorette; scientific advisory board and consulting for Nu Skin; investment in Clarity Cosmetics and Lightwater. Fernanda H Sakamoto: scientific consultant for Beiersdorf and Accure laser; founder of LightWater Bioscience and royalties from Massachusetts General Hospital. Uwe Paasch: equipment from Fotona, GME Medical, Alma Lasers, Zimmer, Canfield, and FotoFinder; research grants from Zimmer; consulting fees/speaker honoraria from Alma Lasers, Fotona, Landsberg, Galderma, DDL, DGPRAEC and Quintessenz publishing. Merete Haedersdal: equipment from Cynosure, GME Medical, and Lutronic; research grants from Galderma, Leo Pharma, L’Oréal/La Roche-Posay; and consulting fees/speaker honoraria from La Roche-Posay, Galderma and Sanofi.
